Related Experiment Videos
Homocysteine and pregnancy.
1Department of Obstetrics, University of Adelaide, Women's and Children's Hospital, North Adelaide, SA 5081, Australia. bill.hague@adelaide.edu.au
Summary
High homocysteine levels (hyperhomocysteinemia) are linked to vascular disease and pregnancy complications. Folate supplementation effectively reduces neural tube defect risk, but other strategies for obstetric pathologies remain elusive.
Area of Science:
- Biochemistry
- Metabolic pathways
- Amino acid metabolism
Background:
- Homocysteine is a key amino acid in methylation and sulphuration pathways.
- Blood homocysteine levels are influenced by diet (folic acid, vitamin B12), renal function, and genetic enzyme variations.
- Hyperhomocysteinemia is associated with vascular disease, though causality is debated.
Purpose of the Study:
- To review the role of homocysteine metabolism in health and disease.
- To examine the association of homocysteine levels with obstetric pathologies.
- To evaluate current strategies for managing homocysteine levels.
Main Methods:
- Literature review of homocysteine metabolism and its clinical implications.
- Analysis of factors affecting homocysteine concentrations.
- Examination of homocysteine's role in pregnancy outcomes.
Main Results:
- Homocysteine concentrations decrease during normal pregnancy.
- Maternal and fetal homocysteine metabolism disturbances are linked to neural tube defects, placental vasculopathy (pre-eclampsia, abruption), and recurrent pregnancy loss.
- Folate supplementation significantly reduces neural tube defect risk.
Conclusions:
- While folate supplementation is effective for neural tube defects, reliable strategies to mitigate other homocysteine-related obstetric pathologies are not yet established.
- Further research is needed to understand and manage homocysteine's impact on pregnancy outcomes.